BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11154985)

  • 1. Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers.
    Passetto Falcão R; Pinto Simões B; Garcia AB; Fonseca BA; Terra Filho J
    Acta Haematol; 2000; 104(2-3):110-4. PubMed ID: 11154985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
    Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
    Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-large granular lymphocyte leukemia accompanied by an increase of natural killer cells (CD3-) and associated with ulcerative colitis and autoimmune hepatitis.
    Kondo H; Watanabe J; Iwasaki H
    Leuk Lymphoma; 2001 Mar; 41(1-2):207-12. PubMed ID: 11342376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.
    Matsuo Y; Drexler HG
    Leuk Res; 2003 Oct; 27(10):935-45. PubMed ID: 12860014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.
    Yagita M; Huang CL; Umehara H; Matsuo Y; Tabata R; Miyake M; Konaka Y; Takatsuki K
    Leukemia; 2000 May; 14(5):922-30. PubMed ID: 10803526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
    Drexler HG; Matsuo Y
    Leukemia; 2000 May; 14(5):777-82. PubMed ID: 10803505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells.
    Hart DN; Baker BW; Inglis MJ; Nimmo JC; Starling GC; Deacon E; Rowe M; Beard ME
    Blood; 1992 Apr; 79(8):2116-23. PubMed ID: 1314113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NK-cell lymphomas and NK-like T-cell lymphomas].
    Oshimi K
    Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.
    Costello RT; Sivori S; Mallet F; Sainty D; Arnoulet C; Reviron D; Gastaut JA; Moretta A; Olive D
    Leukemia; 2002 May; 16(5):855-60. PubMed ID: 11986947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia.
    Gentile TC; Uner AH; Hutchison RE; Wright J; Ben-Ezra J; Russell EC; Loughran TP
    Blood; 1994 Oct; 84(7):2315-21. PubMed ID: 7522625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
    Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
    Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TIA-1 and TIA-2 in T cell malignancies and T cell lymphocytosis.
    Matutes E; Coelho E; Aguado MJ; Morilla R; Crawford A; Owusu-Ankomah K; Catovsky D
    J Clin Pathol; 1996 Feb; 49(2):154-8. PubMed ID: 8655683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association.
    Matano S; Nakamura S; Nakamura S; Annen Y; Hattori N; Kobayashi K; Kyoda K; Sugimoto T
    Acta Haematol; 1999; 101(4):206-8. PubMed ID: 10436303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens.
    Matsuo Y; Drexler HG; Takeuchi M; Tanaka M; Orita K
    Leuk Res; 2002 Sep; 26(9):873-9. PubMed ID: 12127564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large granular lymphocyte proliferation with the natural killer-cell phenotype.
    Chan WC; Gu LB; Masih A; Nicholson J; Vogler WR; Yu G; Nasr S
    Am J Clin Pathol; 1992 Mar; 97(3):353-8. PubMed ID: 1543158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive acute CD3+, CD56- T cell large granular lymphocyte leukemia with two stages of maturation arrest.
    Tordjman R; Macintyre E; Emile JF; Valensi F; Ribrag V; Burtin ML; Varet B; Brousse N; Hermine O
    Leukemia; 1996 Sep; 10(9):1514-9. PubMed ID: 8751472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
    Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
    Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual immunophenotype of T-cell large granular lymphocytic leukemia: report of two cases.
    Rabade N; Mansukhani D; Khodaiji S; Padte B; Bhave A; Tembhare P; Subramanian PG; Sehgal K
    Indian J Pathol Microbiol; 2015; 58(1):108-12. PubMed ID: 25673609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.